SER insider transaction filings
Serina Therapeutics, Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-23. Screen SER transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-23 | 4 | Simon Farrell — Director | Grant/award (A): 30,500 (derivative) @ $0 | EDGAR |
| 2026-07-09 | 4 | Brannan Stephen K. — Director | Purchase (P): 1,000 @ $2.03 | EDGAR |
| 2026-06-22 | 4 | Marshall Richard Peter — Director | Grant/award (A): 15,250 (derivative) @ $0 | EDGAR |
| 2026-06-22 | 4 | Brannan Stephen K. — Director | Grant/award (A): 15,250 (derivative) @ $0 | EDGAR |
| 2026-06-22 | 4 | Venkatesan Jay — Director | Purchase (P): 589 @ $1.78 · Conversion (C): 224,152 @ $2.25 · Grant/award (A): 15,250 (derivative) @ $0 · Conversion (C): 96,525 (derivative) @ $2.25 | EDGAR |
| 2026-06-22 | 4 | Bailey Gregory — Director | Conversion (C): 1,770,805 @ $2.25 · Conversion (C): 6,666,667 @ $2.25 · Grant/award (A): 15,250 (derivative) @ $0 · Grant/award (A): 3,333,333 (derivative) @ $0 · Conversion (C): 762,548 (derivative) @ $2.25 | EDGAR |
| 2026-06-22 | 4 | WILSON KAREN J — Director | Grant/award (A): 15,250 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | WILSON KAREN J — Director | Purchase (P): 5,100 @ $1.75 · Purchase (P): 5,000 @ $1.77 | EDGAR |
| 2026-05-27 | 4 | LEDGER STEVEN A — Chief Executive Officer, Director | Grant/award (A): 10,100 @ $1.93 | EDGAR |
| 2026-05-26 | 4 | Tenjarla Srini — SVP, CMC & Formulation | Grant/award (A): 85,558 (derivative) @ $0 | EDGAR |
| 2026-05-26 | 4 | Moreadith Randall — Chief Scientific Officer | Grant/award (A): 85,558 (derivative) @ $0 | EDGAR |
| 2026-05-26 | 4 | WILSON KAREN J — Director | Purchase (P): 10,000 @ $1.77 · Purchase (P): 10,000 @ $1.93 | EDGAR |
| 2026-05-26 | 4 | CURHAN GREGORY S — Chief Financial Officer | Grant/award (A): 123,019 (derivative) @ $0 | EDGAR |
| 2026-05-26 | 4 | LEDGER STEVEN A — Chief Executive Officer, Director | Grant/award (A): 380,825 (derivative) @ $0 | EDGAR |
| 2026-05-22 | 4 | Marshall Richard Peter — Director | Purchase (P): 12,183 @ $1.65 | EDGAR |
| 2026-04-21 | 4 | Venkatesan Jay — Director | Grant/award (A): 7,553 @ $1.94 | EDGAR |
| 2026-04-21 | 4 | Bailey Gregory — Director | Grant/award (A): 59,667 @ $1.94 | EDGAR |
| 2026-03-24 | 4 | Moreadith Randall — Chief Scientific Officer | Option exercise (M): 6,500 @ $0.06 · Sale (S): 6,500 @ $2.86 · Option exercise (M): 6,500 (derivative) @ $0 | EDGAR |
| 2026-03-20 | 4 | Moreadith Randall — Chief Scientific Officer | Option exercise (M): 39,000 @ $0.06 · Sale (S): 39,000 @ $2.50 · Option exercise (M): 39,000 (derivative) @ $0 | EDGAR |
| 2026-02-17 | 4 | Tenjarla Srini — SVP, CMC & Formulation | Grant/award (A): 69,000 (derivative) @ $0 | EDGAR |
| 2026-02-17 | 4 | Moreadith Randall — Chief Scientific Officer | Grant/award (A): 69,000 (derivative) @ $0 | EDGAR |
| 2026-02-17 | 4 | GILL SIMBA — Director | Grant/award (A): 92,000 (derivative) @ $0 | EDGAR |
| 2026-02-17 | 4 | LEDGER STEVEN A — Chief Executive Officer, Director | Grant/award (A): 230,100 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | Moreadith Randall — Chief Scientific Officer | Option exercise (M): 6,500 @ $0.06 · Sale (S): 6,500 @ $3.03 · Option exercise (M): 6,500 (derivative) @ $0 | EDGAR |
| 2026-01-29 | 4 | Moreadith Randall — Chief Scientific Officer | Option exercise (M): 6,500 @ $0.06 · Sale (S): 6,500 @ $3.57 · Option exercise (M): 6,500 (derivative) @ $0 | EDGAR |
| 2026-01-23 | 4 | Moreadith Randall — Chief Scientific Officer | Option exercise (M): 2,500 @ $0.06 · Sale (S): 2,500 @ $2.95 · Option exercise (M): 2,500 (derivative) @ $0 | EDGAR |
| 2026-01-21 | 4 | Moreadith Randall — Chief Scientific Officer | Option exercise (M): 2,000 @ $0.06 · Sale (S): 2,000 @ $3.07 · Option exercise (M): 2,000 @ $0.06 · Sale (S): 2,000 @ $3 · Option exercise (M): 2,000 (derivative) @ $0 · Option exercise (M): 2,000 (derivative) @ $0 | EDGAR |
| 2026-01-14 | 4 | Moreadith Randall — Chief Scientific Officer | Option exercise (M): 5,416 @ $0.06 · Sale (S): 5,416 @ $2.50 · Option exercise (M): 1,084 @ $0.06 · Sale (S): 1,084 @ $2.50 · Option exercise (M): 5,416 (derivative) @ $0 · Option exercise (M): 1,084 (derivative) @ $0 | EDGAR |
| 2026-01-09 | 4 | Moreadith Randall — Chief Scientific Officer | Option exercise (M): 13,000 @ $0.06 · Sale (S): 13,000 @ $2.69 · Option exercise (M): 13,000 (derivative) @ $0 | EDGAR |
| 2025-12-29 | 4 | Moreadith Randall — Chief Scientific Officer | Option exercise (M): 4,100 @ $0.06 · Sale (S): 4,100 @ $2.60 · Option exercise (M): 4,100 (derivative) @ $0 | EDGAR |
| 2025-12-23 | 4 | Moreadith Randall — Chief Scientific Officer | Option exercise (M): 5,673 @ $0.06 · Sale (S): 5,673 @ $2.67 · Option exercise (M): 5,673 (derivative) @ $0 | EDGAR |
| 2025-12-17 | 4 | Moreadith Randall — Chief Scientific Officer | Option exercise (M): 3,227 @ $0.06 · Sale (S): 3,227 @ $2.96 · Option exercise (M): 3,227 (derivative) @ $0 | EDGAR |
| 2025-12-16 | 4 | Moreadith Randall — Chief Scientific Officer | Option exercise (M): 1,700 @ $0.06 · Sale (S): 1,700 @ $3.26 · Option exercise (M): 1,700 (derivative) @ $0 | EDGAR |
| 2025-12-12 | 4 | Moreadith Randall — Chief Scientific Officer | Option exercise (M): 3,555 @ $0.06 · Sale (S): 3,555 @ $3.24 · Option exercise (M): 3,555 (derivative) @ $0 | EDGAR |
| 2025-12-11 | 4 | Moreadith Randall — Chief Scientific Officer | Option exercise (M): 600 @ $0.06 · Sale (S): 600 @ $3.31 · Grant/award (A): 645 @ $0.06 · Sale (S): 645 @ $3.35 · Option exercise (M): 600 (derivative) @ $0 · Option exercise (M): 645 (derivative) @ $0 | EDGAR |
| 2025-12-04 | 4 | Moreadith Randall — Chief Scientific Officer | Option exercise (M): 1,500 @ $0.06 · Sale (S): 1,500 @ $3.91 · Option exercise (M): 5,000 @ $0.06 · Sale (S): 5,000 @ $3.52 · Option exercise (M): 1,500 (derivative) @ $0 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2025-11-26 | 4 | Moreadith Randall — Chief Scientific Officer | Option exercise (M): 5,965 @ $0.06 · Sale (S): 5,965 @ $3.90 · Option exercise (M): 5,965 (derivative) @ $0 | EDGAR |
| 2025-11-25 | 4 | Moreadith Randall — Chief Scientific Officer | Option exercise (M): 535 @ $0.06 · Sale (S): 535 @ $3.94 · Option exercise (M): 535 (derivative) @ $0 | EDGAR |
| 2025-11-19 | 4 | Moreadith Randall — Chief Scientific Officer | Option exercise (M): 6,500 @ $0.06 · Sale (S): 6,500 @ $3.75 · Option exercise (M): 6,500 (derivative) @ $0 | EDGAR |
| 2025-11-12 | 4 | Moreadith Randall — Chief Scientific Officer | Option exercise (M): 6,500 @ $0.06 · Sale (S): 6,500 @ $4.10 · Option exercise (M): 6,500 (derivative) @ $0 | EDGAR |
| 2025-11-10 | 4 | Marshall Richard Peter — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2025-11-10 | 4 | Brannan Stephen K. — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2025-11-10 | 4 | Venkatesan Jay — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2025-11-10 | 4 | Bailey Gregory — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2025-11-10 | 4 | WILSON KAREN J — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2025-11-06 | 4 | Moreadith Randall — Chief Scientific Officer | Option exercise (M): 3,398 @ $0.06 · Sale (S): 3,398 @ $4.24 · Option exercise (M): 3,398 (derivative) @ $0 | EDGAR |
| 2025-11-05 | 4 | Moreadith Randall — Chief Scientific Officer | Option exercise (M): 3,102 @ $0.06 · Sale (S): 3,102 @ $4.40 · Option exercise (M): 3,102 (derivative) @ $0 | EDGAR |
| 2025-10-29 | 4 | Moreadith Randall — Chief Scientific Officer | Option exercise (M): 5,551 @ $0.06 · Sale (S): 5,551 @ $4.96 · Option exercise (M): 5,551 (derivative) @ $0 | EDGAR |
| 2025-10-28 | 4 | Moreadith Randall — Chief Scientific Officer | Option exercise (M): 949 @ $0.06 · Sale (S): 949 @ $5.19 · Option exercise (M): 949 (derivative) @ $0 | EDGAR |
| 2025-10-21 | 4 | Moreadith Randall — Chief Scientific Officer | Option exercise (M): 6,500 @ $0.06 · Sale (S): 6,500 @ $4.97 · Option exercise (M): 6,500 (derivative) @ $0 | EDGAR |
Recent 8-K events — Serina Therapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-23 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-22 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-06-24 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-14 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-21 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | EDGAR |
| 2026-03-25 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-23 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-28 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-15 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=SER returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →